Skip to main content
Clinical Trials/NCT01741961
NCT01741961CompletedNot Applicable

4-year Follow-up After Ahmed Glaucoma Valve Implantation for Lowering Intraocular Pressure in Different Types of Glaucoma

Technische Universität Dresden1 site in 1 country214 target enrollmentStarted: June 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
214
Locations
1
Primary Endpoint
intraocular pressure reduction

Study Overview

Brief Summary

Long term results after Ahmed glaucoma valve implantation for uncontrolled glaucoma are retrospectively examined.

Detailed Description

The development of intraocular pressure, visual acuity, number of glaucoma medication, number of complications and necessity of revision operations after Ahmed glaucoma valve implantation for uncontrolled glaucoma is examined yearly for a period of 4 years.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients suffering from medically uncontrolled glaucoma
  • Informed consent

Exclusion Criteria

  • healthy subjects
  • under 18 years

Outcomes

Primary Outcomes

intraocular pressure reduction

Time Frame: 4 years

The reduction of intraocular pressure after Ahmed glaucoma valve implantation is observed over a period of 4 years.

Secondary Outcomes

  • development of visual acuity(4 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Karin Pillunat

Principal Investigator

Technische Universität Dresden

Study Sites (1)

Loading locations...

Similar Trials